期刊
INTERNATIONAL JOURNAL OF NEUROSCIENCE
卷 123, 期 5, 页码 353-357出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/00207454.2012.760561
关键词
JC virus; progressive multifocal leukoencephalopathy; natalizumab; cerebrospinal fluid; brain biopsy
The development of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab is a well-known potential risk. Diagnosis of PML can be confounded in patients with multiple sclerosis (MS) if new demyelinating lesions develop, and the sensitivity of existing diagnostic tests is less than ideal. In the case presented here, four samples of cerebrospinal fluid tested negative for John Cunningham virus (JCV) DNA by polymerase chain reaction, yet brain biopsy eventually proved positive by immunohistochemistry. A review of the limitations of existing clinical diagnostic tests is addressed, and we review the most recent literature on the proper management of natalizumab-treated MS patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据